Efficacy And Safety of Early Invasive Vs Conservative Strategies for Non–St-Elevation Acute Coronary Syndromes in Older Patients: An Updated Systematic Review

Q: What is the clinical evidence from this study?

Study design: Systematic Review. Population: Non-ST-segment elevation acute coronary syndrome (NSTE-ACS) (n=350000). Intervention: Early invasive strategy vs. Conservative strategy. Primary outcome: Major Adverse Cardiovascular Events (MACE) (20-30% relative risk reduction).

Q: What does this research mean for the field?

In elderly patients with non–ST-elevation acute coronary syndromes, early invasive management reduces major adverse cardiovascular events, recurrent myocardial infarction, and revascularization compared with conservative therapy, but confers a two- to three-fold increased risk of major bleeding. Novelty: ClaimNovelty.SYNTHESIS. Consensus alignment: ConsensusAlignment.NEUTRAL.

Dr. Akshay Devendra Dhore; Dr. Akshay Devendra Dhore; Dr. Jeevika Saurabh Ande

doi:10.64252/m1b6he88

December 20, 2024International Journal of Environmental SciencesOpen Access

Efficacy And Safety of Early Invasive Vs Conservative Strategies for Non–St-Elevation Acute Coronary Syndromes in Older Patients: An Updated Systematic Review

View Full Paper

Ask AI

Bookmark

Share

Key result

Early invasive strategy cuts MACE ~25% in elderly NSTE-ACS, despite higher major bleeding.

20-30% relative risk reduction
n=350,000

Why the study?

Management of elderly patients with NSTE-ACS is challenging due to balancing ischemic risk reduction with bleeding, frailty, and comorbidities, necessitating comparison of early invasive versus conservative strategies.

Does an early invasive strategy reduce mortality and MACE in elderly patients with NSTE-ACS compared to a conservative strategy?

Key Points

To evaluate the efficacy and safety of early invasive versus conservative management strategies in elderly patients presenting with non–ST-segment elevation acute coronary syndrome.
Systematic search of PubMed, Scopus, Web of Science, and Google Scholar following PRISMA guidelines for studies published between 2015 and 2025.
Included 11 studies (5 randomized controlled trials, 3 systematic reviews, and 3 prospective observational studies) encompassing over 350,000 patients aged ≥65 years (mean age range: 69.3–86 years).
Risk of bias in randomized trials was independently evaluated using the Cochrane Collaboration tool across seven key domains.
Invasive strategies achieved an estimated 20–30% relative risk reduction in major adverse cardiovascular events (pooled incidence ~25% vs. ~35–40%), alongside an estimated 10–20% relative reduction in all-cause mortality across most studies.
Invasive care reduced unplanned or urgent revascularization by >50% relative risk and decreased recurrent myocardial infarction (IRR=0.76 in one trial), yielding gains of +276 days of event-free survival at 5 years.
The procedural approach increased major bleeding by approximately 2- to 3-fold (absolute increase of 8–12%; rates of 14–16% vs. 2–6% in one trial), with early harm observed in patients with high frailty (clinical frailty scale >4).

Study Design

Type

Systematic Review (n=350,000)

Structured PICO

Does an early invasive strategy reduce mortality and MACE in elderly patients with NSTE-ACS compared to a conservative strategy?

P

Population

Over 350,000 elderly patients (aged ≥65 years) with NSTE-ACS included in 11 studies comparing early invasive versus conservative management strategies.

I

Intervention

Early invasive strategy (inpatient coronary angiography followed by revascularization when indicated).

C

Comparator

Conservative (ischemia-guided) strategy (optimal medical therapy, with coronary angiography reserved for patients who develop recurrent symptoms or demonstrate high-risk features).

O

Outcome

Mortality and major adverse cardiovascular events (MACE).composite

Main Result

Effect estimate: 20-30% relative risk reduction

Early invasive strategies in elderly patients with NSTE-ACS significantly reduce ischemic events and the need for revascularization, but increase major bleeding risk, necessitating individualized decision-making based on frailty and comorbidities.

Limitations

Mortality benefits were inconsistent across individual RCTs, particularly in very elderly or frail patients.
Invasive therapy carried a two- to three-fold higher risk of major bleeding.
Advantages of invasive management were attenuated in patients with advanced age, frailty, or prior coronary interventions.
A notable fraction of included studies exhibited a substantial risk of bias in certain domains.

Implication

Supports early invasive management in selected elderly NSTE-ACS patients despite bleeding risk; extends RCT evidence via large pooled analyses.

Abstract

Background: Cardiovascular disease remains the leading cause of morbidity and mortality worldwide, with non–ST-segment elevation acute coronary syndrome (NSTE-ACS) representing a common presentation in older adults. Management of this population is challenging due to the balance between reducing ischemic risk and minimizing bleeding, frailty-related complications, and comorbidities. This systematic review aimed to compare the efficacy and safety of early invasive versus conservative strategies in elderly patients with NSTE-ACS. Methodology: A systematic search of PubMed, Scopus, Web of Science, and Google Scholar was conducted for studies published between 2015 and 2025, following PRISMA guidelines. Eligible studies included patients aged ≥65 years with NSTE-ACS who received either invasive or conservative treatment. Eleven studies (five randomized controlled trials, three systematic reviews, and three prospective observational studies) comprising over 350,000 patients were included. Data extraction covered mortality, major adverse cardiovascular events (MACE), myocardial infarction, revascularization rates, bleeding outcomes, and quality-of-life measures. Risk of bias was assessed using the Cochrane Collaboration tool. Results: This review included 11 studies (5 RCTs, 3 systematic reviews, and 3 prospective observational studies) involving over 350,000 elderly patients (mean age 69–86 years). Invasive strategies were consistently associated with reduced MACE, recurrent myocardial infarction, and unplanned revascularization compared with conservative therapy. Mortality benefits were observed in pooled analyses but remained inconsistent across individual RCTs, particularly in very elderly or frail patients. Event-free survival was longer, and early angina relief more common with invasive treatment, though differences diminished over time. A trade-off was evident, with invasive therapy carrying a two- to three-fold higher risk of major bleeding. Overall, invasive management provided significant ischemic and functional benefits, though its advantages were attenuated in patients with advanced age, frailty, or prior coronary interventions. Conclusion: Early invasive strategies offer significant ischemic and functional benefits in elderly patients with NSTE-ACS, though increased bleeding risk and variable mortality outcomes necessitate individualized decision-making. Frailty and comorbidities should guide therapeutic choices to optimize outcomes.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Dhore et al. (2024) conducted a systematic review in Non-ST-segment elevation acute coronary syndrome (NSTE-ACS) (n=350,000). Early invasive strategy vs. Conservative strategy was evaluated on Major Adverse Cardiovascular Events (MACE) (20-30% relative risk reduction). Early invasive strategies in elderly patients with NSTE-ACS significantly reduced MACE, recurrent myocardial infarction, and unplanned revascularization, though with a higher risk of major bleeding.

synapsesocial.com/papers/6ac1abb2cc6172083c928af0 https://doi.org/10.64252/m1b6he88

View Full Paper

Ask AI

Bookmark

Share

Efficacy And Safety of Early Invasive Vs Conservative Strategies for Non–St-Elevation Acute Coronary Syndromes in Older Patients: An Updated Systematic Review

Key Points

Study Design

Structured PICO

Main Result

Limitations

Implication

Abstract

Discussion

Cite This Study

Efficacy And Safety of Early Invasive Vs Conservative Strategies for Non–St-Elevation Acute Coronary Syndromes in Older Patients: An Updated Systematic Review

Key Points

Study Design

Structured PICO

Main Result

Limitations

Implication

Abstract

Discussion

Cite This Study

Keep reading

Keep reading